The metastatic breast cancer cell line, MDA‐MB‐231‐Br (231‐Br), which was isolated from brain metastases, was selected as the model tumor for in vitro assays because of its ease of growth and sensitivity to TRAIL. The gene discussed is TNFSF10; the disease is breast carcinoma.